Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels

References

• AltschulRHofferAStephenJDInfluence of nicotinic acid on serum cholesterol in manArch Biochem Biophys1955545589
   PubMed Web of Science ®Google Scholar
• AssmannGSchulteHFunkeHThe emergence of triglycerides as a significant independent risk factor in coronary artery diseaseEur Heart J199819Suppl MM819821011
   PubMedGoogle Scholar
• AtarIKorkmazMEDemircanSBeta blocker effects on plasma homocysteine levels in patients with hypertensionAtherosclerosis200518139940216039296
   PubMed Web of Science ®Google Scholar
• BasuTKMannSVitamin B-6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacin’s hypolipidemic effectsJ Nutr1997127117219040554
   PubMed Web of Science ®Google Scholar
• BissonnetteRTreacyERozenRFenofibrate raises plasma homocysteine levels in the fasted and fed statesAtherosclerosis2001155455611254917
   PubMed Web of Science ®Google Scholar
• BögerRHLentzSRBode-BögerSMElevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humansClin Sci (Lond)2001100161711171285
   PubMed Web of Science ®Google Scholar
• BourqueCSt-OngeMPPapamandjarisAAConsumption of an oil composed of medium chain triacyglycerols, phytosterols, and N-3 fatty acids improves cardiovascular risk profile in overweight womenMetabolism2003527717 200312800105
   PubMed Web of Science ®Google Scholar
• BousheyCJBeresfordSAOmennGSA quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesJAMA19952741049577563456
   PubMed Web of Science ®Google Scholar
• BroedersNKnoopCAntoineMFibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?Nephrol Dial Transplant2000151993911096145
   PubMed Web of Science ®Google Scholar
• BrownWVPotential use of fenofibrate and fibric acid derivatives in the clinicAm J Med1987838593688012
   PubMed Web of Science ®Google Scholar
• CabriniLBochicchioDBordoniACorrelation between dietary polyunsaturated fatty acids and plasma homocysteine concentration in vitamin B6-deficient ratsNutr Metab Cardiovasc Dis20051594915871857
   PubMed Web of Science ®Google Scholar
• CelermajerDSSorensenKEGoochVMNon-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisLancet19923401111151359209
   PubMed Web of Science ®Google Scholar
• ChambersJCObeidOAKoonerJSPhysiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjectsArterioscler Thromb Vasc Biol1999192922710591670
   PubMed Web of Science ®Google Scholar
• ClarkeRHomocysteine-lowering trials for prevention of heart disease and strokeSemin Vasc Med20055215216047274
   PubMedGoogle Scholar
• CleophasTJHornstraNvan HoogstratenBHomocysteine, a risk factor for coronary artery disease or not? A meta-analysisAm J Cardiol20008610059A811053715
   PubMed Web of Science ®Google Scholar
• de LorgerilMSalenPPaillardFLipid-lowering drugs and homocysteineLancet199935320919923885
   PubMed Web of Science ®Google Scholar
• DierkesJJeckelAAmbroschAFactors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam studyMetabolism2001506406411398138
   PubMed Web of Science ®Google Scholar
• DierkesJWestphalSKunstmannSVitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrateAtherosclerosis2001158161411500187
   PubMed Web of Science ®Google Scholar
• DierkesJWestphalSLuleyCSerum homocysteine increases after therapy with fenofibrate or bezafibrateLancet19993542192010421307
   PubMed Web of Science ®Google Scholar
• FordESSmithSJStroupDFHomocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studiesInt J Epidemiol200231597011914295
   PubMed Web of Science ®Google Scholar
• FreisEDThe efficacy and safety of diuretics in treating hypertensionAnn Intern Med199512222367810942
   PubMed Web of Science ®Google Scholar
• FruchartJCDuriezPHDL and triglyceride as therapeutic targetsCurr Opin Lipidol2002136051612441884
   PubMed Web of Science ®Google Scholar
• FruchartJCStaelsBDuriezPThe role of fibric acids in atherosclerosisCurr Atherosclerosis Rep200138392
   PubMedGoogle Scholar
• GargRMalinowMPettingerMNiacin treatment increases plasma homocyst(e)ine levelsAm Heart J19991381082710577438
   PubMed Web of Science ®Google Scholar
• GenestJFrohlichJSteinerGEffect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitusAm J Cardiol2004938485315050487
   PubMed Web of Science ®Google Scholar
• GiralPBruckertEJacobNHomocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemiaAtherosclerosis2001154421711166775
   PubMed Web of Science ®Google Scholar
• GottoAMJrReview of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatinAm J Cardiol2005965A34F8F
   PubMed Web of Science ®Google Scholar
• GrundtHNilsenDWHetlandOAtherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemiaThromb Haemost199981561510235439
   PubMed Web of Science ®Google Scholar
• GrundtHNilsenDWMansoorMAReduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised dou-ble-blind study following an acute myocardial infarction: no effect on endothelial adhesion propertiesPathophysiol Haemost Thromb200333889514624050
   PubMedGoogle Scholar
• HaratsDYodfatODoolmanRHomocysteine elevation with fibrates: is it a class effect?Isr Med Assoc J20013243611344833
   PubMed Web of Science ®Google Scholar
• Homocysteine Lowering Trialists’ CollaborationDose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trialsAm J Clin Nutr2005828061216210710
   PubMed Web of Science ®Google Scholar
• Homocysteine Lowering Trialists’ CollaborationLowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trialsBMJ199831689489569395
   PubMedGoogle Scholar
• Homocysteine Studies CollaborationHomocysteine and risk of ischemic heart disease and stroke: a meta-analysisJAMA200228820152212387654
   PubMed Web of Science ®Google Scholar
• HottelartCel EsperNAchardJMFenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency [French]Nephrologie19992041410081035
   PubMedGoogle Scholar
• HottelartCEl EsperNRoseFFenofibrate increases creatininemia by increasing metabolic production of creatinineNephron200292364112187082
   PubMed Web of Science ®Google Scholar
• JacquesPFBostomAGWilsonPWRosenbergIHSelhubJDeterminants of plasma total homocysteine concentration in the Framingham Offspring cohortAm J Clin Nutr2001731362111124743
   PubMed Web of Science ®Google Scholar
• JeppesenJHeinHOSuadicaniPTriglyceride concentration and ischemic heart disease: an eight-year follow up in the Copenhagen Male StudyCirculation199897102910369531248
   PubMed Web of Science ®Google Scholar
• JonkersIJAMde ManFHAFOnkenhoutWImplications of fibrate therapy for homocysteineLancet1999354120810513736
   PubMedGoogle Scholar
• KeechASimesRJBarterPFIELD study investigatorsEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialLancet200536618496116310551
   PubMed Web of Science ®Google Scholar
• KellyPJRosandJKistlerJPHomocysteine, MTHFR 677C--> T polymorphism, and risk of ischemic stroke: results of a meta-analysisNeurology2002595293612196644
   PubMed Web of Science ®Google Scholar
• KezdiPKezdiPCKhamisHJDiuretic induced long term hemodynamic changes in hypertension. A retrospective study in a MRFIT clinical centerClin Exp Hypertens1992A1434765
   Google Scholar
• KhanKNMPharmacology of cyclooxygenase-2 inhibition in the kidneyKidney Int20026112101911918727
   PubMed Web of Science ®Google Scholar
• KnoppRHDrug treatment of lipid disordersN Engl J Med199934149851110441607
   PubMed Web of Science ®Google Scholar
• KorkmazMEAtarITayfunEEffects of a beta-blocker and spironolactone on plasma homocysteine levelsInt J Cardiol200388119212659999
   PubMed Web of Science ®Google Scholar
• LandrayMJTownendJNMartinSLipid-lowering drugs and homocysteineLancet19993531974197510371600
   PubMed Web of Science ®Google Scholar
• LangeHSuryapranataHDe LucaGFolate therapy and in-stent restenosis after coronary stentingN Engl J Med200435026738115215483
   PubMed Web of Science ®Google Scholar
• LegendreCCausseEChaputEFenofibrate induces a selective increase of protein-bound homocysteine in rodents: a PPARalpha-medi-ated effectBiochem Biophys Res Commun20022951052612135600
   PubMed Web of Science ®Google Scholar
• LiHLewisABrodskySHomocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?Circulation200210510374311877351
   PubMed Web of Science ®Google Scholar
• LiemAReynierse-BuitenwerfGHZwindermanAHSecondary prevention with folic acid: effects on clinical outcomesJ Am Coll Cardiol20034121051312821232
   PubMed Web of Science ®Google Scholar
• LipscombeJBargmanJMFibrate-induced increase in blood urea and creatinineNephrol Dial Transplant200116151511427661
   PubMed Web of Science ®Google Scholar
• LucGJacobNBoulyMFenofibrate increases homocystinemia through a PPARalpha-mediated mechanismJ Cardiovasc Pharmacol200443452315076230
   PubMed Web of Science ®Google Scholar
• MacMahonMKirkpatrickCCummingsCEA pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)Nutr Metab Cardiovasc Dis20001019520311079257
   PubMed Web of Science ®Google Scholar
• MayerOJrSimonJHolubecLFolate co-administration improves the effectiveness of fenofibrate to decrease the lipoprotein oxidation and endothelial dysfunction surrogatesPhysiol Res2005 2005 Dec 12; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• MayerOJrSimonJHolubecLFenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administrationEur J Clin Pharmacol2003593677112845504
   PubMed Web of Science ®Google Scholar
• MelenovskyVStulcTKozichVEffect of folic acid on fenofibrate-induced elevation of homocysteine and cysteineAm Heart J200314611012851616
   PubMed Web of Science ®Google Scholar
• MelenovskyVMalikJWichterleDComparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemiaAm Heart J2002144E612360175
   PubMedGoogle Scholar
• MilionisHJPapakostasJKakafikaAComparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemiaJ Clin Pharmacol2003438253012953339
   PubMed Web of Science ®Google Scholar
• MollerJNielsenGMTvedegaardKCA meta-analysis of cerebrovascular disease and hyperhomocysteinaemiaScand J Clin Lab Invest200060491911129065
   PubMed Web of Science ®Google Scholar
• MonteneroASDrugs producing vitamin deficienciesActa Vitaminol Enzymol1980227457211625
   PubMedGoogle Scholar
• MorrowLEGrimsleyEWLong-term diuretic therapy in hypertensive patients: effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrationsSouth Med J1999928667010498160
   PubMed Web of Science ®Google Scholar
• MuddSHPooleJRLabile methyl balances for normal humans on various dietary regimensMetabolism1975247217351128236
   PubMed Web of Science ®Google Scholar
• NappoFDe RosaNMarfellaRImpairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitaminsJAMA199928121131810367822
   PubMed Web of Science ®Google Scholar
• NygardONordrehaugJEPlasma homocysteine levels and mortality in patients with coronary artery diseaseN Engl J Med199733723069227928
   PubMed Web of Science ®Google Scholar
• NygardOVollsetSERefsumHTotal plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine StudyJAMA19952741526337474221
   PubMed Web of Science ®Google Scholar
• OlszewskiAJMcCullyKSFish oil decreases serum homocysteine in hyperlipemic menCoron Artery Dis1993453608269183
   PubMed Web of Science ®Google Scholar
• ParhoferKGBeyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis preventionExp Clin Endocrinol Diabetes20051134141716151973
   PubMed Web of Science ®Google Scholar
• PiolotABlacheDBouletLEffect of fish oil on LDL oxidation and plasma homocysteine concentrations in healthJ Lab Clin Med200314141912518167
   PubMed Web of Science ®Google Scholar
• RidkerPMShihJCookTJAir Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Investigators. Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary eventsCirculation20021051776911956118
   PubMed Web of Science ®Google Scholar
• SchnyderGRoffiMPinRDecreased rate of coronary restenosis after lowering of plasma homocysteine levelsN Engl J Med20013451593160011757505
   PubMed Web of Science ®Google Scholar
• SebestjenMKeberIZeguraBStatin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factorsThromb Haemost20049211293515543343
   PubMed Web of Science ®Google Scholar
• SharabiYDoolmanRRosenthalTHomocysteine levels in hypertensive patients with a history of cardiac or cerebral atherothrombotic eventsAm J Hypertens1999127667110480468
   PubMedGoogle Scholar
• Sutton-TyrrellKBostomASelhubJHigh homocysteine levels are independently related to isolated systolic hypertension in older adultsCirculation199716174599323056
   PubMedGoogle Scholar
• StulcTMelenovskyVGrauovaBFolate supplementation prevents plasma homocysteine increase after fenofibrate therapyNutrition200117721311527658
   PubMed Web of Science ®Google Scholar
• StulcTKasalovaZKrejciHEffect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetesAtherosclerosis2005183367816165140
   PubMed Web of Science ®Google Scholar
• SyvanneMWhittallRATurpeinenUSerum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosisAtherosclerosis20041722677215019536
   PubMed Web of Science ®Google Scholar
• TawakolAOmlandTGerhardMHyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humansCirculation1997951119219054838
   PubMed Web of Science ®Google Scholar
• ThambyrajahJLandrayMJJonesHJA randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery diseaseJ Am Coll Cardiol20013718586311401123
   PubMed Web of Science ®Google Scholar
• ThambyrajahJTownendJNHomocysteine and atherothrombosis—mechanisms for injuryEur Heart J2000219677410901508
   PubMed Web of Science ®Google Scholar
• THE BIP STUDY GROUPSecondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) studyCirculation200010221710880410
   PubMed Web of Science ®Google Scholar
• The Diabetes Atherosclerosis Intervention Study InvestigatorsEffect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised studyLancet200124; 35790510
   Web of Science ®Google Scholar
• TooleJFMalinowMRChamblessLELowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trialJAMA20042915657514762035
   PubMed Web of Science ®Google Scholar
• van GuldenerCNanayakkaraPWStehouwerCDHomocysteine and blood pressureCurr Hypertens Rep20035263112530932
   PubMed Web of Science ®Google Scholar
• WaldDSLawMMorrisJKHomocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ2002325120212446535
   PubMed Web of Science ®Google Scholar
• WangWBasingerANeeseRAEffect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride productionAm J Physiol Endocrinol Metab2001280E54054711171611
   PubMed Web of Science ®Google Scholar
• WelchGNLoscalzoJHomocysteine and atherothrombosisN Engl J Med19983381042509535670
   PubMed Web of Science ®Google Scholar
• WestphalSDierkesJLuleyCEffects of fenofibrate and gemfibrozil on plasma homocysteineLancet2001358394011454380
   PubMed Web of Science ®Google Scholar
• WestphalSRadingALuleyCDierkesJAntihypertensive treatment and homocysteine concentrationsMetabolism200352261312647260
   PubMed Web of Science ®Google Scholar
• WilsonKMLentzSRMechanisms of the atherogenic effects of elevated homocysteine in experimental modelsSemin Vasc Med200551637116047268
   PubMedGoogle Scholar
• WilsonMWLayLTChowCKAltered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acidArch Toxicol19956949178526745
   PubMed Web of Science ®Google Scholar
• YoshinariMAsanoTKaoriSEffect of gemfibrozil on serum levels of prostacyclin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetesDiabetes Res Clin Pract199842149549925344
   PubMed Web of Science ®Google Scholar
• ZemanMZakAVeckaMN-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combinationJ Nutr Biochem2006173798416214329
   PubMed Web of Science ®Google Scholar
• ZhaoXQMorseJSDowdyAASafety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)Am J Cardiol2004933071214759379
   PubMed Web of Science ®Google Scholar